cGMP contract manufacturing and process development for cell and gene therapies
GeneFab operates a biofoundry focused on manufacturing and scaling cell and gene therapies from early design through cGMP production. The hiring profile—predominantly manufacturing-focused with senior roles and a Cell Therapy Lead—reflects active investment in production scale-up, while project work on automated system transitions and method validation indicates a shift away from manual, open processes toward tighter process control and compliance infrastructure.
Notable leadership hires: Cell Therapy Lead
GeneFab provides contract manufacturing and synthetic biology services to cell and gene therapy developers. The company spans three service layers: early-stage design work using bioinformatic discovery and directed evolution of gene switches; technical development and process optimization; and cGMP-compliant manufacturing. Founded in 2023 and based in Alameda, California, GeneFab operates as a biofoundry with approximately 51–200 employees, the majority in manufacturing and production roles.
Primary tools include Veeva QualityDocs (quality and compliance), Microsoft Office suite (Word, Excel, Project, PowerPoint), DocuSign, Smartsheet, SharePoint, and LIMS for laboratory data management.
Alameda, California. All current hiring is within the United States.
Other companies in the same industry, closest in size